The Zacks Analyst Blog Eli Lilly, J&J, AbbVie, AstraZeneca and PfizerZacks Investment Research • 01/03/25
AbbVie (ABBV) Rises Yet Lags Behind Market: Some Facts Worth KnowingZacks Investment Research • 12/24/24
My Dividend Stock Portfolio: New November Dividend Record - 97 Holdings With 18 BuysSeeking Alpha • 12/18/24
Alzamend Neuro to Present Non-Clinical Data Update at the Society of Toxicology 2025 Annual Meeting and ToxExpoBusiness Wire • 12/18/24
AbbVie Takes On Pfizer And Merck With Its Next Leg Of Growth. Will AbbVie Stock Come Back?Investors Business Daily • 12/17/24
ABBV to Acquire Nimble Therapeutics to Strengthen Immunology PipelineZacks Investment Research • 12/16/24
AbbVie to Acquire Nimble Therapeutics, Further Strengthening Immunology PipelinePRNewsWire • 12/13/24
Alzamend Neuro Reports Second Quarter 2025 Financial Results and Provides Update on Clinical ProgramsBusiness Wire • 12/12/24